Autologous tumor infiltrating lymphocytes (TILs)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Autologous tumor infiltrating lymphocytes (TILs), covering 2020-09-04 to 2025-09-22. Get the full timeline:
Most recent: Clinical Trial Update: Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases [Phase 1]